VanEck Associates’s Oracle ORCL Stock Holding History

VanEck Associates’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$123M	Sell	837,918 -14,262	-2%	-$2.32M	0.09%	169
2025 Q4	$166M	Buy	852,180 +811,985	+2,020%	+$193M	0.14%	138
2025 Q3	$11.3M	Sell	40,195 -1,010,541	-96%	-$257M	0.01%	500
2025 Q2	$230M	Sell	1,050,736 -159,639	-13%	-$25.8M	0.26%	85
2025 Q1	$169M	Buy	1,210,375 +1,181,810	+4,137%	+$192M	0.22%	108
2024 Q4	$4.76M	Sell	28,565 -31	-0.1%	-$5.51K	0.01%	714
2024 Q3	$4.95M	Sell	28,596 -1,089	-4%	-$158K	0.01%	645
2024 Q2	$4.19M	Sell	29,685 -72	-0.2%	-$8.94K	0.01%	643
2024 Q1	$3.74M	Sell	29,757 -5,183	-15%	-$593K	0.01%	681
2023 Q4	$3.68M	Sell	34,940 -89	-0.3%	-$9.71K	0.01%	630
2023 Q3	$3.71M	Buy	35,029 +6,187	+21%	+$716K	0.01%	580
2023 Q2	$3.44M	Sell	28,842 -142	-0.5%	-$14.7K	0.01%	601
2023 Q1	$2.69M	Sell	28,984 -100	-0.3%	-$8.77K	0.01%	624
2022 Q4	$2.38M	Buy	29,084 +892	+3%	+$67.8K	0.01%	641
2022 Q3	$1.72M	Buy	28,192 +322	+1%	+$23.6K	0.01%	683
2022 Q2	$1.95M	Sell	27,870 -4,608	-14%	-$337K	0.01%	659
2022 Q1	$2.69M	Buy	32,478 +490	+2%	+$39.7K	0.01%	638
2021 Q4	$2.79M	Sell	31,988 -7,123	-18%	-$669K	0.01%	629
2021 Q3	$3.41M	Buy	39,111 +5,043	+15%	+$445K	0.01%	547
2021 Q2	$2.65M	Buy	34,068 +1,466	+4%	+$115K	0.01%	596
2021 Q1	$2.29M	Buy	32,602 +1,741	+6%	+$113K	0.01%	580
2020 Q4	$2M	Sell	30,861 -143,990	-82%	-$8.57M	0.01%	542
2020 Q3	$10.4M	Sell	174,851 -25,081	-13%	-$1.42M	0.03%	257
2020 Q2	$11.1M	Sell	199,932 -917	-0.5%	-$48.6K	0.04%	243
2020 Q1	$9.71M	Buy	200,849 +122	+0.1%	+$6.3K	0.05%	216
2019 Q4	$10.6M	Buy	200,727 +100,853	+101%	+$5.55M	0.04%	247
2019 Q3	$5.5M	Buy	99,874 +3,158	+3%	+$174K	0.03%	330
2019 Q2	$5.51M	Buy	96,716 +8,660	+10%	+$469K	0.03%	319
2019 Q1	$4.73M	Sell	88,056 -6,990	-7%	-$356K	0.02%	325
2018 Q4	$4.29M	Buy	95,046 +8,489	+10%	+$407K	0.02%	328
2018 Q3	$4.46M	Buy	86,557 +6,527	+8%	+$317K	0.02%	345
2018 Q2	$3.53M	Buy	+80,030	New	+$3.69M	0.02%	361
2017 Q2	–	Sell	-39,319	Closed	-$1.75M	–	840
2017 Q1	$1.75M	Buy	39,319 +2,552	+7%	+$106K	0.01%	422
2016 Q4	$1.41M	Buy	36,767 +1,969	+6%	+$77K	0.01%	437
2016 Q3	$1.37M	Buy	34,798 +9,056	+35%	+$369K	0.01%	449
2016 Q2	$1.05M	Buy	25,742 +5,254	+26%	+$210K	0.01%	469
2016 Q1	$838K	Buy	20,488 +1,878	+10%	+$69.5K	0.01%	472
2015 Q4	$680K	Buy	18,610 +3,687	+25%	+$141K	0.01%	434
2015 Q3	$539K	Buy	14,923 +2,178	+17%	+$83.7K	﹤0.01%	462
2015 Q2	$514K	Buy	12,745 +1,642	+15%	+$71.2K	﹤0.01%	496
2015 Q1	$479K	Buy	11,103 +5,249	+90%	+$227K	﹤0.01%	500
2014 Q4	$263K	Buy	+5,854	New	+$238K	﹤0.01%	544
2014 Q1	–	Sell	-749,647	Closed	-$28.7M	–	707
2013 Q4	$28.7M	Buy	749,647 +195,610	+35%	+$6.72M	0.14%	107
2013 Q3	$18.4M	Buy	554,037 +191,999	+53%	+$6.23M	0.09%	124
2013 Q2	$11.1M	Buy	+362,038	New	+$12M	0.06%	158

Other funds holding ORCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VanEck Associates's ORCL Position: Q1 2026 in Review

VanEck Associates reduced its Oracle (ORCL) stake by 1.7% in Q1 2026, selling an estimated $2.32M and leaving 837,918 shares worth $123M. The position accounts for 0.09% of the portfolio, ranked #169.

VanEck Associates first reported a position in ORCL in Q2 2013 and has held it in 45 quarters since. The position peaked at $230M in Q2 2025. 3,474 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

VanEck Associates held 837,918 shares of Oracle worth $123M as of Q1 2026.
VanEck Associates sold 14,262 Oracle shares in Q1 2026, an estimated $2.32M.
Oracle made up 0.09% of VanEck Associates's portfolio in Q1 2026, its #169 holding.
VanEck Associates first reported a position in Oracle in Q2 2013 and has held it in 45 quarters since.
VanEck Associates's Oracle position peaked at $230M in Q2 2025.
3,474 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.